Northern Trust Corp increased its holdings in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 7.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 770,270 shares of the business services provider's stock after acquiring an additional 53,227 shares during the quarter. Northern Trust Corp owned approximately 1.52% of Exponent worth $68,631,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Aquatic Capital Management LLC raised its position in shares of Exponent by 58.7% in the 4th quarter. Aquatic Capital Management LLC now owns 7,302 shares of the business services provider's stock valued at $651,000 after purchasing an additional 2,702 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in Exponent in the fourth quarter valued at $59,000. Coldstream Capital Management Inc. raised its holdings in Exponent by 7.6% in the fourth quarter. Coldstream Capital Management Inc. now owns 5,552 shares of the business services provider's stock valued at $495,000 after acquiring an additional 393 shares in the last quarter. Two Sigma Securities LLC bought a new position in Exponent during the 4th quarter valued at $227,000. Finally, Price T Rowe Associates Inc. MD grew its holdings in Exponent by 8.5% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 32,053 shares of the business services provider's stock worth $2,856,000 after acquiring an additional 2,517 shares in the last quarter. Hedge funds and other institutional investors own 92.37% of the company's stock.
Exponent Stock Performance
Shares of Exponent stock opened at $75.38 on Tuesday. Exponent, Inc. has a 1 year low of $73.37 and a 1 year high of $115.75. The firm's 50-day simple moving average is $80.39 and its 200-day simple moving average is $89.24. The firm has a market cap of $3.83 billion, a PE ratio of 35.56 and a beta of 0.95.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.04. The firm had revenue of $137.44 million for the quarter, compared to analysts' expectations of $134.63 million. Exponent had a return on equity of 27.27% and a net margin of 19.52%. Exponent's revenue for the quarter was up .2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.59 earnings per share. On average, equities analysts predict that Exponent, Inc. will post 1.98 earnings per share for the current year.
Exponent Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Shareholders of record on Friday, June 6th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.59%. The ex-dividend date of this dividend is Friday, June 6th. Exponent's dividend payout ratio is presently 58.54%.
Insider Buying and Selling at Exponent
In other news, VP Richard Reiss sold 1,736 shares of Exponent stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total value of $149,174.48. Following the completion of the transaction, the vice president now directly owns 1,800 shares of the company's stock, valued at approximately $154,674. The trade was a 49.10 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 2.10% of the stock is owned by insiders.
Exponent Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.